Deflazacort Tablet
Product Images NDC 0832-0814

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deflazacort (NDC 0832-0814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display-panel (6 MG)

Deflazacort Tablets 6 mg oral use carton label by Upsher-Smith Laboratories, LLC. The label indicates 100 tablets per carton with a green 6 mg strength highlighted. It states Rx only and includes storage instructions with distributor information. A barcode is also present on the packaging.*

FDA Label Image

Principal Display-panel (18 MG)

Deflazacort Tablets 18 mg oral use packaging label showing a carton design with text including NDC 0832-0815-30, 30 tablets per container, and Rx only. The labeler is Upsher-Smith Laboratories, LLC, with storage instructions and usual dosage reference. Barcode and other administrative details are visible.*

FDA Label Image

Principal Display-panel (30 MG)

Packaging label for Deflazacort Tablets, 30 mg strength, intended for oral use. The label shows a bottle with 30 tablets. The product is prescription only and manufactured by Upsher-Smith Laboratories, LLC. The label includes storage information, dosage instructions, and a barcode.*

FDA Label Image

Principal Display-panel (36 MG)

Packaging label for Deflazacort 36 mg tablets by Upsher-Smith Laboratories, LLC. The label displays the product name, strength, oral use indication, quantity of 30 tablets, and Rx only designation. It includes storage instructions and distributor details, with a barcode and lot information on the label.*

FDA Label Image

Chemical Structure (Deflazacort 01)

Chemical structure of deflazacort, showing the molecular arrangement of atoms including rings, hydroxyl groups, and ketones characteristic of this corticosteroid compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.